SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

AFFINITY ENERGY AND HEALTH LIMITED (AEB)

Suspended from ASX

SHARE PRICES

Former (or subsequent) names

Shareholder links

 

REGISTRY:

Computershare, Level 11, 172 St Georges Terrace, Perth WA 6000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000AEB3
Address: Ground Floor, 516 Hay Street, SUBIACO, WA, AUSTRALIA, 6008
Tel:  (08) 9380 6790 Fax: (08) 9381 9161

Date first listed: 13/01/2011
Company Secretary: Terry Gardiner
Sector: Energy Industry Group: XEJ
Activities: Renewable energy in the form of commercialisation of the McConchie-Stroud algae production and processing system

Following a resolution passed by creditors at the second meeting of creditors, the Company executed a Deed of Company Arrangement on 24 August 2020 with Benelong Capital Partners and Bryan Hughes and Daniel Bredenkamp were appointed Joint and Several Deed Administrators of the Company on that same day. It is anticipated a shareholders' meeting will be convened in September/October 2020 to consider the proposed share restructure under the DOCA.

24/08/2020

The following entity has not paid their annual listing fees in respect of the year ending 30 June 2021 but their securities are already suspended from official quotation.

24/08/2020

Shareholders in this company should consider crystallising a capital loss in 2020/21 by selling their worthless shares, which they can achieve online by entering transaction details here. While this usually makes good economic sense, we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.

13/08/2020

At the second meeting of creditors held today, creditors resolved that the company execute a recapitalisation DOCA. The recapitalisation DOCA is required to be executed within 15 business days from the date of the second meeting of creditors.

04/08/2020

Expressions of interest are sought from parties interested in acquiring all or part of the company's assets or in submitting a proposal for the recapitalisation and restructure of the company. Parties wishing to express interest should contact Mr Monty Purich at purichm@pitcher-wa.com.au or Mr Chris Pattinson at pattinsonc@pitcher-wa.com.au, or phone + 61 8 9322 2022.

09/07/2020

At approximately 8:00AM on 1 July 2020, the Board of Directors appointed Bryan Hughes and Daniel Bredenkamp of Pitcher Partners as Joint and Several Administrators of the Company pursuant to section 436A of the Corporations Act 2001.

01/07/2020

The Company requests that the voluntary suspension continue until the commencement of trading on Tuesday 23 June 2020 or the release of an announcement regarding the Company's capital raising.

09/06/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 9 June 2020 or the release of an announcement regarding the company's capital raising.

26/05/2020

The Company requests that the voluntary suspension continue until the commencement of trading on Tuesday 26 May 2020 or the release of an announcement regarding its capital raising.

12/05/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 12 May 2020 or the release of an announcement regarding the company's capital raising.

28/04/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 28 April 2020 or the release of an announcement regarding the company's capital raising.

14/04/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 14 April 2020 or the release of an announcement regarding the capital raising.

31/03/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 31 March 2020 or the release of an announcement regarding the company's capital raising.

17/03/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 17 March 2020 or the release of an announcement regarding the capital raising.

03/03/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 3 March 2020 or the release of an announcement regarding the company's capital raising.

18/02/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 18 February 2020 or the release of an announcement regarding the company's capital raising.

04/02/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 4 February 2020 or the release of an announcement regarding the capital raising.

21/01/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 21 January 2020 or the release of an announcement regarding the company's capital raising.

07/01/2020

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 7 January 2020 or the release of an announcement regarding the company's capital raising.

23/12/2019

The company requests that the voluntary suspension continue until the commencement of trading on 24 December 2019 or the release of an announcement regarding the company's capital raising.

16/12/2019

The company releases its Corporate Governance Statement and Appendix 4G.

11/12/2019

The company lodges its 2019 Annual Report.

11/12/2019

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 17 December 2019 or the release of an announcement regarding the company's capital raising.

09/12/2019

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 10 December 2019 or the release of an announcement regarding the capital raising.

26/11/2019

The company requests that the voluntary suspension continue until the commencement of trading on 26 November 2019 or the release of an announcement regarding the capital raising.

11/11/2019

The company lodges its Quarterly Activities Report and Appendix 4C.

01/11/2019

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 12 November 2019 or the release of an announcement regarding the capital raising.

30/10/2019

AEB is nearing completion of its planned corporate and operational restructure which will allow for continued exploitation of the company's algae intellectual property through various licensing and partnering arrangements whilst at the same time removing the debt burden of the existing operational facility. AEB will also continue with its medicinal cannabis developments through the Australian licence application, the granted Malta licence and various strategic relationships currently in place.

25/10/2019

The company requests that the voluntary suspension continue until the commencement of trading on 29 October 2019 or the release of an announcement regarding the capital raising.

14/10/2019

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 15 October 2019 or the release of an announcement regarding the company's capital raising.

01/10/2019

The company requests that the vountary suspension continue unti the commencement of trading on 1 October 2019 or the release of an announcement regarding the capita raising.

16/09/2019

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 17 September 2019 or the release of an announcement regarding the capital raising.

02/09/2019

The company lodges its Appendix 4E Preliminary Final Report.

02/09/2019

The company has not paid their annual listing fees in respect of the year ending 30 June 2020 but the securities are already suspended from official quotation.

22/08/2019

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 3 September 2019 or the release of an announcement regarding the company's capital raising.

19/08/2019

The company requests that the voluntary suspension continue until the commencement of trading on 20 August 2019 or the release of an announcement regarding the company's capital raising.

07/08/2019

The company lodges its Quarterly Activities Report and Appendix 4C.

01/08/2019

The company requests that the voluntary suspension continue until the commencement of trading on 6 August 2019 or the release of an announcement regarding the company's capital raising.

29/07/2019

The company requests an extension of the voluntary suspension of its securities until the commencement of trading on 30 July 2019 or the release of an announcement regarding the company's capital raising.

22/07/2019

The company requests that the voluntary suspension continue until the commencement of trading on 23 July 2019 or the release of an announcement regarding its capital raising.

08/07/2019

The company requests that the voluntary suspension continue until the commencement of trading on 9 July 2019 or the release of an announcement regarding the capital raising.

24/06/2019

The company requests that the voluntary suspension of its securities continue until the commencement of trading on Tuesday 25 June 2019 or the release of an announcement regarding the company's capital raising.

11/06/2019

The company requests an extension of the voluntary suspension of its securities to finalise its capital raising. The voluntary suspension is expected to continue until the commencement of trading on 11 June 2019 or the release of an announcement regarding the matters referred to above.

27/05/2019

The Company requests that the voluntary suspension continue until the commencement of trading on Tuesday 28 May 2019 or the release of an announcement regarding the company's capital raising.

06/05/2019

The company lodges its Quarterly Activities Report and Appendix 4C.

30/04/2019

The company requests an extension of the voluntary suspension of its securities to finalise its capital raising. The extension is requested until the commencement of trading on 7 May 2019 or the release of an announcement.

15/04/2019

The Company requests that the voluntary suspension continue until the commencement of trading on Tuesday 16 April 2019 or the release of an announcement regarding its capital raising.

08/04/2019

The company requests an extension of the voluntary suspension of its securities to finalise its capital raising and the announcement in respect of it. The voluntary suspension is expected to continue until the commencement of trtading on 9 April 2019 or the release of an announcement regarding the matters previously mentioned.

01/04/2019

The company advises the release of shares from voluntary escrow. The shares issued to Medical Cannabis Limited on 6 April 2018 under the Licencing Heads of Agreement announced on 22 December 2017, are due for release from voluntary escrow on 5 April 2019.

25/03/2019

The Company requests that the voluntary suspension continue until the commencement of trading on Tuesday 2 April 2019 or the release of an announcement regarding the capital raising.

25/03/2019

The company requests that the voluntary suspension continue until the commencement of trading on Tuesday 26 March 2019 or the release of an announcement regarding the capital raising.

18/03/2019

The company requests that the suspension continue until the commencement of trading on Tuesday 19 March 2019 or the release of an announcement regarding its capital raising.

11/03/2019

The Company requests that the voluntary suspension continue until the commencement of trading on Tuesday 12 March 2019 or the release of an announcement regarding its capital raising.

05/03/2019

The company lodges its Appendix 4D Half Year Report.

28/02/2019

The Company requests that the voluntary suspension continue until the commencement of trading on Tuesday 5 March 2019 or the release of an announcement regarding its capital raising.

25/02/2019

The company requests an extension of the voluntary suspension of its securities pending a capital raising announcement. The suspension is expected to continue until the commencement of trading on Tuesday 26 February 2019 or the release of an announcement.

18/02/2019

The Company requests that the voluntary suspension continue until the commencement of trading on Tuesday 19 February 2019 or the release of an announcement regarding the capital raising.

11/02/2019

The securities of Affinity Energy and Health Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of AEB, pending the release of an announcement regarding an investment and capital raising.

05/02/2019

name changed from Algae.Tec Limited

20/08/2018

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    05/01/2018Peter Hatfull-2,000,000$0.062$124,000
    23/05/2017Peter Hatfull9,400$0.059$554
    18/05/2017Peter Hatfull40,600$0.059$2,395
    31/01/2017Peter Hatfull1,797$0.054$97
    25/01/2017Peter Hatfull73,203$0.053$3,879

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Qing XuNon Exec Director18/09/2019
    Terry GardinerNon Exec Director24/10/2019
    Jith VeeravalliAlternate Director15/08/2017

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Garnet McConchieExecutive Director18/08/200829/07/2020
    Josh PuckridgeNon Exec Director08/04/201924/10/2019
    Sonu CheemaNon Exec Director14/06/201918/09/2019
    Malcolm JamesExecutive Chairman, Managing Director16/09/201414/06/2019
    R.V. VenkateshNon Exec Director15/08/201708/04/2019
    Peter HatfullExecutive Director18/01/201008/04/2019
    Allan TanNon Exec Director15/08/201714/01/2019
    Jonathan LimNon Exec Director15/08/201707/02/2018
    Roger StroudExecutive Chairman22/03/200716/09/2014
    Timothy MorrisonNon Exec Director18/01/201019/04/2013

    Date of first appointment, title may have changed.